Free Trial
OTCMKTS:CSPCY

CSPC Pharmaceutical Group (CSPCY) Stock Price, News & Analysis

C$2.64 +0.02 (+0.57%)
(As of 04:21 PM ET)

About CSPC Pharmaceutical Group Stock (OTCMKTS:CSPCY)

Key Stats

Today's Range
C$2.50
C$2.64
50-Day Range
C$2.26
C$3.68
52-Week Range
C$2.25
C$3.82
Volume
15,870 shs
Average Volume
41,318 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. It provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson's disease; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; and Keaili for breast cancer. The company also offers Shuluoke, Nuomoling, Weihong, and Xinweihong for various infections; Xuanning for hypertension; Encun to prevent atherosclerotic thrombosis events; Qixiao to treat upper respiratory tract infection; Linmeixin and Shuanglexin for diabetes; Gubang and Gubangjia to treat osteoporosis in postmenopausal women; and Gaoshunsong for arthritis, osteoarthritis, ankylosing spondylitis, frozen shoulder, bursuitis, tenosynovitis, acute gout, dysmenorrhea, toothache and postoperative pain, low back pain, sprain, strain, and other soft tissue injuries. In addition, it provides Debixin for various ulcer; Qimaite for acute and chronic pains; antibiotics, vitamin C, and caffeine APIs; functional food and glucose products; and healthcare services. The company has a strategic partnership with Pfizer Inc. to launch a local brand of the COVID-19 oral therapeutic treatment Nirmatrelvir/Ritonavir in China. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the People's Republic of China.

Receive CSPCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CSPC Pharmaceutical Group and its competitors with MarketBeat's FREE daily newsletter.

CSPCY Stock News Headlines

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Short Interest Update
CSPC Pharmaceutical Group Ltd (CVG.SG)
Trump’s Back, but DC’s Coming for Your Money!
Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…
CSPC Pharmaceutical Group Ltd
CSPC Pharmaceutical Group Ltd 01093
CSPC Pharmaceutical Group Ltd. ADR
China OKs its first mRNA vaccine, from drugmaker CSPC
See More Headlines

CSPCY Stock Analysis - Frequently Asked Questions

CSPC Pharmaceutical Group's stock was trading at C$3.69 at the start of the year. Since then, CSPCY shares have decreased by 28.9% and is now trading at C$2.63.
View the best growth stocks for 2024 here
.

Shares of CSPCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Ex-Dividend for 12/5 Dividend
11/01/2024
Today
11/14/2024
Dividend Payable
12/05/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers—General
Sub-Industry
Personal Services
Current Symbol
OTCMKTS:CSPCY
CIK
N/A
Fax
N/A
Employees
23,500
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

This page (OTCMKTS:CSPCY) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners